Approximately one year after successful treatment with cytotoxic chemotherapy and radiotherapy, patients with
advanced Small Cell Lung Cancer (SCLC), which primarily affects heavy smokers, generally relapse with recurrence of tumours that are resistant to further chemotherapy.
Not exact matches
Dr. Weiss» study of pembrolizumab was presented during a session on
small cell lung cancer when the theme of the conference was Science Drives Lung Cancer Advan
lung cancer when the theme of the conference was Science Drives Lung Cancer Adv
cancer when the theme of the conference was Science Drives
Lung Cancer Advan
Lung Cancer Adv
Cancer Advances.
The research group plans to move forward with more -
advanced technology and larger populations to investigate field cancerization in other
lung cancer subtypes, such as
small -
cell lung cancer, in smokers and in
lung cancers that develop in non-smokers.